酸受体作为瘤中代谢变化的受体的潜力
Zhiying Wang1, Yuanqi Zhang2, Zhihong Liao1
1Laboratory of Vascular Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Frontiers in oncology
|March 4, 2024
概括
癌细胞在瘤微环境 (TME) 中重新编程新陈代谢. 阿里尔碳化合物受体 (AhR) 将TME代谢变化与癌症生长,转移和治疗耐药性联系起来,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 癌细胞表现出代谢重编程以适应营养缺乏和缺氧瘤微环境 (TME).
- 阿里尔碳化合物受体 (AhR) 是一种联体激活的转录因子,与癌症调节有关.
- 瘤和TME细胞都产生AhR配体,这表明它在癌症进展中的作用.
研究的目的:
- 审查TME和癌症代谢之间的相互作用.
- 阐明AhR在调节癌症代谢重编程中的作用.
- 探索AhR作为癌症治疗的潜在治疗标.
主要方法:
- 文献综述侧重于癌症代谢和AhR信号传递.
- 对研究AhR对癌症代谢途径的影响的研究分析.
- 综合目前关于AhR在瘤生长,转移和治疗逃避中的作用的研究结果.
主要成果:
- 由TME衍生的连接体激活AhR,失调了关键的代谢途径,如糖解,脂质和核酸代谢.
- 通过AhR介导的代谢重编程显著促进癌细胞的增殖,转移和对治疗的抵抗.
- 有证据表明,AhR可以作为瘤微环境中的代谢变化的传感器.
结论:
- 在调解癌症中代谢重编程的影响方面,AhR起着至关重要的作用.
- 了解AhR在瘤代谢中的作用,为癌症进展提供了新的见解.
- 准AhR为未来的癌症治疗干预提供了一个有希望的战略.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cell Signaling in Plants
5.6K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.6K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


